HAP Trading’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $762K | Sell |
91,200
-5,600
| -6% | -$384K | 0.05% | 214 |
|
|
2025
Q2 | $593K | Buy |
96,800
+9,600
| +11% | +$630K | 0.06% | 174 |
|
|
2025
Q1 | $515K | Sell |
87,200
-6,900
| -7% | -$413K | 0.06% | 186 |
|
|
2024
Q4 | $61.5K | Buy |
94,100
+53,800
| +133% | +$3.02M | 0.01% | 444 |
|
|
2024
Q3 | $172K | Sell |
40,300
-15,800
| -28% | -$922K | 0.02% | 328 |
|
|
2024
Q2 | $166K | Buy |
+56,100
| New | +$3.51M | 0.02% | 310 |
|
|
2024
Q1 | – | Sell |
-228,400
| Closed | -$296K | – | 789 |
|
|
2023
Q4 | $296K | Buy |
228,400
+202,700
| +789% | +$14.4M | 0.05% | 244 |
|
|
2023
Q3 | $35.5K | Sell |
25,700
-15,700
| -38% | -$1.11M | 0.01% | 576 |
|
|
2023
Q2 | $36.2K | Buy |
41,400
+22,500
| +119% | +$1.6M | 0.01% | 562 |
|
|
2023
Q1 | $10K | Buy |
18,900
+100
| +0.5% | +$8.39K | ﹤0.01% | 881 |
|
|
2022
Q4 | $75K | Sell |
18,800
-15,500
| -45% | -$1.5M | 0.01% | 643 |
|
|
2022
Q3 | $104K | Buy |
34,300
+8,700
| +34% | +$861K | 0.01% | 784 |
|
|
2022
Q2 | $107K | Sell |
25,600
-17,800
| -41% | -$1.74M | 0.01% | 869 |
|
|
2022
Q1 | $364K | Sell |
43,400
-18,100
| -29% | -$1.9M | 0.02% | 644 |
|
|
2021
Q4 | $895K | Buy |
61,500
+6,400
| +12% | +$591K | 0.02% | 511 |
|
|
2021
Q3 | $276K | Buy |
55,100
+26,100
| +90% | +$2.19M | 0.01% | 902 |
|
|
2021
Q2 | $232K | Sell |
29,000
-5,000
| -15% | -$409K | 0.01% | 948 |
|
|
2021
Q1 | $95K | Sell |
34,000
-316,800
| -90% | -$23.1M | 0.01% | 972 |
|
|
2020
Q4 | $1.04M | Buy |
350,800
+43,400
| +14% | +$2.82M | 0.03% | 414 |
|
|
2020
Q3 | $335K | Sell |
307,400
-58,200
| -16% | -$3.62M | 0.02% | 498 |
|
|
2020
Q2 | $1.45M | Buy |
365,600
+37,900
| +12% | +$2.39M | 0.08% | 222 |
|
|
2020
Q1 | $1.11M | Sell |
327,700
-5,245
| -2% | -$350K | 0.07% | 201 |
|
|
2019
Q4 | $3.39M | Sell |
332,945
-255,000
| -43% | -$17.9M | 0.19% | 83 |
|
|
2019
Q3 | $1.94M | Buy |
587,945
+185,700
| +46% | +$11M | 0.16% | 120 |
|
|
2019
Q2 | $856K | Buy |
402,245
+247,000
| +159% | +$13.3M | 0.07% | 243 |
|
|
2019
Q1 | $55K | Sell |
155,245
-98,432
| -39% | -$6.08M | ﹤0.01% | 654 |
|
|
2018
Q4 | $52K | Sell |
253,677
-6,023
| -2% | -$450K | ﹤0.01% | 744 |
|
|
2018
Q3 | $953K | Buy |
259,700
+46,300
| +22% | +$3.31M | 0.06% | 217 |
|
|
2018
Q2 | $194K | Buy |
213,400
+147,300
| +223% | +$9.71M | 0.01% | 470 |
|
|
2018
Q1 | $10K | Buy |
66,100
+48,200
| +269% | +$3.46M | ﹤0.01% | 820 |
|
|
2017
Q4 | $12K | Buy |
+17,900
| New | +$1.3M | ﹤0.01% | 846 |
|
|
2017
Q3 | – | Sell |
-182,600
| Closed | -$998K | – | 921 |
|
|
2017
Q2 | $998K | Sell |
182,600
-819,900
| -82% | -$64.7M | 0.05% | 261 |
|
|
2017
Q1 | $2.03M | Buy |
1,002,500
+680,900
| +212% | +$54.4M | 0.13% | 134 |
|
|
2016
Q4 | $639K | Buy |
+321,600
| New | +$26M | 0.03% | 316 |
|
|
2015
Q1 | – | Sell |
-130,000
| Closed | -$2.79M | – | 979 |
|
|
2014
Q4 | $2.79M | Hold |
130,000
| – | – | 0.1% | 163 |
|
|
2014
Q3 | $751K | Hold |
130,000
| – | – | 0.03% | 401 |
|
|
2014
Q2 | $491K | Sell |
130,000
-23,100
| -15% | -$1.75M | 0.02% | 450 |
|
|
2014
Q1 | $787K | Buy |
153,100
+114,000
| +292% | +$8.05M | 0.04% | 370 |
|
|
2013
Q4 | $315K | Buy |
+39,100
| New | +$2.51M | 0.01% | 652 |
|
Other funds holding CVS
HAP Trading's CVS Position: Q1 2025 in Review
HAP Trading sold out of CVS Health (CVS) in Q1 2025, closing a stake of 55,720 shares — an estimated $3.33M sold.
HAP Trading first reported a position in CVS in Q2 2013 and held it in 24 quarters. The position peaked at $26.4M in Q3 2018. 1,753 funds tracked by Wall St. Rank hold CVS as of Q1 2025.
- HAP Trading reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
- HAP Trading sold 55,720 CVS Health shares in Q1 2025, an estimated $3.33M.
- HAP Trading first reported a position in CVS Health in Q2 2013 and held it in 24 quarters.
- HAP Trading's CVS Health position peaked at $26.4M in Q3 2018.
- 1,753 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.
Based on HAP Trading's 13F filing for Q1 2025, filed 14 May 2025.